168 related articles for article (PubMed ID: 11451746)
1. Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism.
Yoshida M; Sawada T; Ishii H; Gerszten RE; Rosenzweig A; Gimbrone MA; Yasukochi Y; Numano F
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1165-71. PubMed ID: 11451746
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions.
Kawakami A; Tanaka A; Nakajima K; Shimokado K; Yoshida M
Circ Res; 2002 Aug; 91(3):263-71. PubMed ID: 12169653
[TBL] [Abstract][Full Text] [Related]
3. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M
Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191
[TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells.
Denoyelle C; Albanese P; Uzan G; Hong L; Vannier JP; Soria J; Soria C
Cell Signal; 2003 Mar; 15(3):327-38. PubMed ID: 12531431
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
[TBL] [Abstract][Full Text] [Related]
7. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
Weber C; Erl W; Weber KS; Weber PC
J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect.
Vincent L; Chen W; Hong L; Mirshahi F; Mishal Z; Mirshahi-Khorassani T; Vannier JP; Soria J; Soria C
FEBS Lett; 2001 Apr; 495(3):159-66. PubMed ID: 11334884
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
12. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
Wagner AH; Gebauer M; Güldenzoph B; Hecker M
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
[TBL] [Abstract][Full Text] [Related]
13. Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models.
Vincent L; Soria C; Mirshahi F; Opolon P; Mishal Z; Vannier JP; Soria J; Hong L
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):623-9. PubMed ID: 11950701
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase.
Toriumi Y; Hiraoka M; Watanabe M; Yoshida M
FEBS Lett; 2003 Oct; 553(3):419-22. PubMed ID: 14572662
[TBL] [Abstract][Full Text] [Related]
15. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions.
Weber C; Erl W; Weber KS; Weber PC
Clin Chem Lab Med; 1999 Mar; 37(3):243-51. PubMed ID: 10353467
[TBL] [Abstract][Full Text] [Related]
16. Integral role of RhoA activation in monocyte adhesion-triggered tissue factor expression in endothelial cells.
Ishibashi T; Sakamoto T; Ohkawara H; Nagata K; Sugimoto K; Sakurada S; Sugimoto N; Watanabe A; Yokoyama K; Sakamoto N; Kurabayashi M; Takuwa Y; Maruyama Y
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):681-7. PubMed ID: 12692008
[TBL] [Abstract][Full Text] [Related]
17. Rho is a negative regulator of human monocyte spreading.
Aepfelbacher M; Essler M; Huber E; Czech A; Weber PC
J Immunol; 1996 Dec; 157(11):5070-5. PubMed ID: 8943416
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes.
Ishibashi T; Nagata K; Ohkawara H; Sakamoto T; Yokoyama K; Shindo J; Sugimoto K; Sakurada S; Takuwa Y; Teramoto T; Maruyama Y
Biochim Biophys Acta; 2002 Jun; 1590(1-3):123-30. PubMed ID: 12063175
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine modulates THP-1 cell adhesion to vascular endothelium via inhibition of protein kinase C signal transduction.
Yu T; Morita I; Shimokado K; Iwai T; Yoshida M
Hypertension; 2003 Sep; 42(3):329-34. PubMed ID: 12900427
[TBL] [Abstract][Full Text] [Related]
20. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
